Projects per year
Abstract
Interleukin-1β (IL-1β) is activated by inflammasome-associated caspase-1 in rare autoinflammatory conditions and in a variety of other inflammatory diseases. Therefore, IL-1β activity must be fine-tuned to enable anti-microbial responses whilst limiting collateral damage. Here, we show that precursor IL-1β is rapidly turned over by the proteasome and this correlates with its decoration by K11-linked, K63-linked and K48-linked ubiquitin chains. The ubiquitylation of IL-1β is not just a degradation signal triggered by inflammasome priming and activating stimuli, but also limits IL-1β cleavage by caspase-1. IL-1β K133 is modified by ubiquitin and forms a salt bridge with IL-1β D129. Loss of IL-1β K133 ubiquitylation, or disruption of the K133:D129 electrostatic interaction, stabilizes IL-1β. Accordingly, Il1bK133R/K133R mice have increased levels of precursor IL-1β upon inflammasome priming and increased production of bioactive IL-1β, both in vitro and in response to LPS injection. These findings identify mechanisms that can limit IL-1β activity and safeguard against damaging inflammation.
Original language | English |
---|---|
Article number | 2713 |
Number of pages | 16 |
Journal | Nature Communications |
Volume | 12 |
Issue number | 1 |
DOIs | |
Publication status | Published - Dec 2021 |
-
Role of A1 in repressing mitochondrial apoptosis to limit pathogen clearance
Lawlor, K. (Primary Chief Investigator (PCI))
1/01/20 → 31/12/23
Project: Research
-
Role of programmed cell death in NLRP3 inflammasome activation and Metabolic Syndrome
Lawlor, K. (Primary Chief Investigator (PCI))
1/01/19 → 31/12/22
Project: Research
-
Unconventional mechanisms for activating the NLRP3 inflammasome
Vince, J. (Primary Chief Investigator (PCI)), Murphy, J. (Chief Investigator (CI)), Lawlor, K. (Chief Investigator (CI)) & Lindqvist, L. M. (Chief Investigator (CI))
1/01/18 → 31/12/20
Project: Research